Immunomodulatory properties of nickel-doped ferric-based nanoparticles in vitro

Main Article Content

Lenka Rajsiglova
Dmitry Stakheev
Katerina Krausova
Pavol Lukac
Paolo Tenti
Michal Babic
Daniel Smrž
Luca Vannucci

Abstract

Iron-based nanoparticles (NPs) represent small nanocarriers made of iron oxides. These nanoparticles include magnetite NPs (Fe3O4), maghemite NPs (γ-Fe2O3), or mixed ferrites (metal-doped iron oxide NPs; MFe2O4, where M can be Co, Ni, Zn, or Mn). Due to their unique characteristics, including biocompatibility, reported selective toxicity towards cancer cells, magnetic imaging capabilities, and hyperthermic properties, they are regarded as a promising modality for cancer treatments. In this context, it is crucial to assess the impact of these NPs on immune anti-cancer responses, as immunosuppressive effects on immune cells are undesirable in cancer therapies and may compromise the outcome of the treatment.


For this purpose, we initially investigated the direct anti-cancer effects of FN NPs (ferric oxide-based NPs doped with Ni) on the CT26 (murine colorectal adenocarcinoma) cell line. To evaluate the immune response to the treated cancer cells, syngeneic bone marrow-derived dendritic cells (BMDCs) were pulsed with the lysates of FN NP-pretreated CT26 cells. These BMDCs were maturated overnight and analyzed by flow cytometry for expression of maturation markers. A portion of the prepared BMDCs was additionally co-cultured with T cells, and their activation was assessed by examining the production of IFN-γ and TNF-α, along with the expression of PD-1 and TIM-3 using flow cytometry.


Our experiments demonstrated that FN nanoparticles exhibit a direct, dose-dependent toxic effect and an increased apoptotic rate in the CT26 cancer cell line. No immunosuppressive effects were detected concerning the expression of maturation markers of FN NP-CT26-pulsed and maturated BMDCs or their functional capacity to activate syngeneic T cells. The activation of T cells was demonstrated by the production of pro-inflammatory IFN-γ and TNF-α. Moreover, no changes were detected in the expression of PD-1 and TIM-3 checkpoint molecules linked with the exhausted T cell phenotype.


In conclusion, the evaluated FN NPs displayed direct anti-cancer toxicity within our experimental model while preserving the immune response to the cancer cells. These findings imply that the nanoconstruct may be a viable candidate for anti-cancer interventions.


Acknowledgements: The research was supported by Next Generation EU (NPO Exceles NCI, reg. n. LX22NPO5102), the Ministry of Health, Czech Republic (project NU23-08-00071), institutional grant RVO 61388971 of the Institute of Microbiology AS CR, v.v.i., and donations by: Generali/Ceska pojistovna a.s. (CZ), UniCredit Bank a.s. (CZ&SK), Eurinox s.r.o (CZ).


 

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Rajsiglova L, Stakheev D, Krausova K, Lukac P, Tenti P, Babic M, et al. Immunomodulatory properties of nickel-doped ferric-based nanoparticles in vitro. SEE J Immunol [Internet]. 2025 Mar. 25 [cited 2026 Nov. 17];8(CITIM):077. Available from: https://seejim.eu/index.php/seejim/article/view/6140
Section
Posters

Most read articles by the same author(s)

Similar Articles

<< < 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.